Cite
[Cariprazine, a new type - dopamine D₃ receptor preferring - partial agonist atypical antipsychotic for the treatment of schizophrenia and the primary negative symptoms]
MLA
Istvan, Laszlovszky, et al. “[Cariprazine, a New Type - Dopamine D₃ Receptor Preferring - Partial Agonist Atypical Antipsychotic for the Treatment of Schizophrenia and the Primary Negative Symptoms].” Neuropsychopharmacologia Hungarica : A Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology, vol. 21, no. 3, Sept. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........544c332938157869e9b0aeac42ab1316&authtype=sso&custid=ns315887.
APA
Istvan, L., Bela, K., Agota, B., Margit, K., & Gyorgy, N. (2019). [Cariprazine, a new type - dopamine D₃ receptor preferring - partial agonist atypical antipsychotic for the treatment of schizophrenia and the primary negative symptoms]. Neuropsychopharmacologia Hungarica : A Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology, 21(3).
Chicago
Istvan, Laszlovszky, Kiss Bela, Barabassy Agota, Kapas Margit, and Nemeth Gyorgy. 2019. “[Cariprazine, a New Type - Dopamine D₃ Receptor Preferring - Partial Agonist Atypical Antipsychotic for the Treatment of Schizophrenia and the Primary Negative Symptoms].” Neuropsychopharmacologia Hungarica : A Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology 21 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........544c332938157869e9b0aeac42ab1316&authtype=sso&custid=ns315887.